Mahoney Michael F's Form 4 filing
Boston Scientific Corp (BSX) · filed May 5, 2025
- Accession no.
- 0001225208-25-004717
- Filed
- May 5, 2025
- Trade date
- May 1, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $16.9M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mahoney Michael FCIK 0001533022 | Director, Officer (Chairman, President & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 1, 2025 | Common Stock | MOption exerciseAcquired | +56,212 | $17.26 | +$970,219.12 | 1,650,742 | Direct | |
| May 1, 2025 | Common Stock | MOption exerciseAcquired | +49,407 | $24.55 | +$1,212,941.85 | 1,700,149 | Direct | |
| May 1, 2025 | Common Stock | SSaleDisposed | −73,161 | $102.92F2 | −$7,529,730.12 | 1,626,988 | Direct | |
| May 1, 2025 | Common Stock | SSaleDisposed | −91,282 | $102.13F3 | −$9,322,630.66 | 1,535,706 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 1, 2025 | Common Stock | MOption exerciseDisposed | −56,212 | $0.00 | $0 | 56,212 | Direct | |
| May 1, 2025 | Common Stock | MOption exerciseDisposed | −49,407 | $0.00 | $0 | 197,628 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $102.64 to $103.34, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F3
Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $101.61 to $102.60, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.